Seven-day therapy for Helicobacter pylori in the United States

Alimentary Pharmacology & Therapeutics
Nimish VakilJ Barth

Abstract

The ideal duration of Helicobacter pylori treatment in the United States and whether eradication therapy is as successful in nonulcer dyspepsia as in peptic ulcer disease are controversial topics. This study compared the efficacy of 3-, 7- and 10-day triple therapies with rabeprazole to a 10-day omeprazole control triple therapy for the eradication of Helicobacter pylori in patients with and without peptic ulcer disease in the United States. This was a multicentre, double-blind, randomized, parallel-group trial. A total of 803 patients with H. pylori infection (determined by [13C]urea breath test and rapid urease test or culture) received either rabeprazole 20 mg b.d., amoxicillin 1000 mg b.d., and clarithromycin 500 mg b.d. for 3, 7, or 10 days, or 10 days of omeprazole 20 mg b.d. with the same antibiotic regimen (control). H. pylori status was assessed by [13C]urea breath test > or =6 weeks after completing treatment. In intent-to-treat patients, the eradication percentages achieved for the rabeprazole-based treatments were: 3-day, 27% (95% confidence interval: 21%-34%); 7-day, 77% (95% confidence interval: 71%-83%); and 10-day, 78% (95% confidence interval: 72%-84%). The eradication percentage with the 10-day omeprazole-base...Continue Reading

References

Sep 1, 1993·Digestive Diseases and Sciences·A TucciL Barbara
Mar 28, 1998·The American Journal of Gastroenterology·L TrevisaniV Abbasciano
May 7, 1998·Alimentary Pharmacology & Therapeutics·H J O'ConnorK Cunnane
Jul 1, 1998·The American Journal of Gastroenterology·X CalvetM Navarro
Sep 11, 1998·The American Journal of Gastroenterology·N VakilD McSorley
Mar 23, 1999·The American Journal of Gastroenterology·A Henry, R G Batey
May 16, 2000·Archives of Internal Medicine·W L PetersonL Laine
Mar 20, 2001·Thorax·UNKNOWN British Thoracic Society Standards of Care Committee
Oct 13, 2001·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·C ChahineA I Sharara
Feb 28, 2002·Alimentary Pharmacology & Therapeutics·P MalfertheinerUNKNOWN European Helicobacter Pylori Study Group (EHPSG)

❮ Previous
Next ❯

Citations

Aug 6, 2008·European Journal of Clinical Pharmacology·Shaojun Shi, Ulrich Klotz
Aug 20, 2010·Internal and Emergency Medicine·Luigi GattaCarmelo Scarpignato
Mar 17, 2005·Current Treatment Options in Gastroenterology·Mae F Go
Mar 22, 2013·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Gul JavidRiyaz U Saif
Oct 26, 2013·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Mukesh NasaPrabha Sawant
Jan 18, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Ernst J Kuipers
May 1, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·David Y Graham, Akiko Shiotani
Oct 8, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·Colm A O'Morain, J P Anthony O'Connor
Dec 17, 2009·Journal of Clinical Gastroenterology·David Yates Graham, Massimo Rugge
Dec 20, 2005·Journal of Gastroenterology and Hepatology·P W Y LimB C Y Wong
Sep 12, 2007·Journal of Gastroenterology and Hepatology·György M Buzás, Jolán Józan
Jan 22, 2011·Journal of Gastroenterology and Hepatology·Varocha MahachaiRatha-Korn Vilaichone
Jul 29, 2011·Journal of Gastroenterology and Hepatology·Jun-Won ChungJin-Ho Kim
Mar 30, 2012·Clinical and Experimental Gastroenterology·Javier P Gisbert, Xavier Calvet
Aug 8, 2012·Drugs·Raymond S Tang, Francis K L Chan
Sep 23, 2008·World Journal of Gastroenterology : WJG·Javier P Gisbert
Sep 2, 2010·World Journal of Gastroenterology : WJG·Satoshi MamoriHajime Yamada
Jun 2, 2012·World Journal of Gastroenterology : WJG·Hyuk Soon ChoiHo Sang Ryu
Dec 14, 2012·World Journal of Gastroenterology : WJG·Jai Hoon YoonHyun Joo Jang
Aug 18, 2012·ISRN Gastroenterology·M GasparettoG Guariso
May 23, 2013·European Journal of Clinical Pharmacology·Hassan SeddikAhmed Benkirane
Jun 29, 2007·Digestive Diseases and Sciences·Angelo ZulloDino Vaira
Jun 13, 2006·Der Internist·P Malfertheiner, M Bellutti
Aug 9, 2011·Expert Review of Anti-infective Therapy·Michael SelgradPeter Malfertheiner
Oct 1, 2007·Expert Review of Gastroenterology & Hepatology·Nicholas J Talley, Zhang Li
Nov 26, 2005·Expert Review of Anti-infective Therapy·Ala I Sharara
May 1, 2009·Expert Review of Clinical Pharmacology·Alex Mejia, Walter K Kraft
Jan 22, 2013·Expert Opinion on Pharmacotherapy·Sotirios D GeorgopoulosStylianos Karatapanis
Dec 9, 2009·Expert Opinion on Drug Metabolism & Toxicology·Jyh-Chin Yang, Chun-Jung Lin
May 9, 2008·Expert Opinion on Drug Safety·Avelyn KwokRupert Wl Leong
Feb 25, 2009·Expert Opinion on Drug Safety·Alia Dadabhai, Frank K Friedenberg
Feb 16, 2005·Expert Opinion on Pharmacotherapy·Hidekazu Suzuki, Toshifumi Hibi
Jul 26, 2011·Lancet·Claude Matuchansky
Sep 8, 2010·European Journal of Internal Medicine·Javier P Gisbert, José María Pajares
Jul 27, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·David Y Graham
Oct 7, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Deng-Chyang WuDavid Y Graham
Nov 23, 2006·The Medical Clinics of North America·Jason CollinsDuane T Smoot
Aug 2, 2006·Gastroenterology Clinics of North America·Ratha-Korn VilaichoneDavid Y Graham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.